Dyslipidemia International Survey-China

计划入组 25,000 人 · 首次发布于 2012 年 11 月 26 日

Capital Mãe

计划入组 446 人

Chiron Corp HCV E1/E2 Vaccine

计划入组 60 人 · 首次发布于 2007 年 7 月 13 日

SNA-1 (SyneuRx International(SyneuRx International (Taiwan) Corp.)

PAD4 inhibitors(Capital Medical University)

IGC-AD1

Strategem Capital Corp

United States

Copland Road Capital Corp

Broad Capital Acquisition Corp

Innogen Pharmaceutical Soars 296% in Hong Kong Debut Following GLP-1 Diabetes Drug Approval

Singapore Biotech Mirxes Achieves $1 Billion Valuation with Hong Kong IPO, Becomes First Southeast Asian Unicorn

Jingze Bio Files Third HKEX IPO Application, Spotlighting Biosimilar Competition in China's Fertility and Ophthalmology Markets